Jessica Santander

Jessica Santander

Auto-generated profile, based on publicly available information

Jessica Santander

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2023 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
LZLaura Zuluaga
Laura Zuluaga
JCJuan Ignacio Caicedo
Juan Ignacio Caicedo
MMMaría Paula Mogollón
María Paula Mogollón
JSJessica Santander
Jessica Santander
ABAlejandra Bravo-Balado
Alejandra Bravo-Balado
MPMauricio Plata
Mauricio Plata

1 November 2008 in Transplantation Proceedings
Verified
Journal Article
Closed access
VPV. Pinto
V. Pinto
JGJ. Grandy
J. Grandy
PZP. Zambrano
P. Zambrano
BCB. Corta
B. Corta
PSP. Salas
P. Salas
RGRodrigo Iñiguez García
Rodrigo Iñiguez García

22 December 2022 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
MPMauricio Plata
Mauricio Plata
JSJessica Santander
Jessica Santander
LZLaura Zuluaga
Laura Zuluaga
CTCamilo Torres-Sandoval
Camilo Torres-Sandoval
SVSergio Valencia
Sergio Valencia
CTCarlos Gustavo Trujillo
Carlos Gustavo Trujillo

4 August 2020 in Revista Urología Colombiana / Colombian Urology Journal
Verified
Journal Article
Open access
PDF file
JCJulian Chavarriaga
Julian Chavarriaga
CBCatalina Barco-Castillo
Catalina Barco-Castillo
JSJessica Santander
Jessica Santander
LZLaura Zuluaga
Laura Zuluaga
CMCamilo Medina
Camilo Medina
JCJuan Ignacio Caicedo
Juan Ignacio Caicedo
Introduction Prediction of lymph node involvement (LNI) is of paramount importance for patients with prostate cancer (PCa) undergoing radical prostatectomy (RP). Multiple statistical models predicting LNI have been developed to support clinical decision-making regarding the need of extended pelvic lymph node dissection (ePLND). Our aim is to evaluate the prediction ability of the best-performing prediction tools for LNI in PCa in a Latin-American population.Methods Clinicopathological data of 830 patients with PCa who underwent RP and ePLND between 2007 and 2018 was obtained. Only data from patients who had ≥ 10 lymph nodes (LNs) harvested were included (n = 576 patients). Four prediction models were validated using this cohort: The Memorial Sloan Kettering Cancer Center (MSKCC) web calculator, Briganti v.2017, Yale formula and Partin tables v.2016. The performance of the prediction tools was assessed using the area under the receiver operating characteristic (ROC) curve (AUC).Results The median age was 61 years old (interquartile range [IQR] 56–66), the median Prostate specific antigen (PSA) was 6,81 ng/mL (IQR 4,8–10,1) and the median of LNs harvested was 17 (IQR 13–23), and LNI was identified in 53 patients (9.3%). Predictions from the 2017 Briganti nomogram AUC (0.85) and the Yale formula AUC (0.85) were the most accurate; MSKCC and 2016 Partin tables AUC were both 0,84.Conclusion There was no significant difference in the performance of the four validated prediction tools in a Latin-American population compared with the European or North American patients in whom these tools have been validated. Among the 4 models, the Briganti v.2017 and Yale formula yielded the best results, but the AUC overlapped with the other validated models.

22 December 2021 in Revista Urología Colombiana / Colombian Urology Journal
Verified
Journal Article
Open access
PDF file
NFNicolas Fernandez
Nicolas Fernandez
JSJessica Santander
Jessica Santander
MPMarcela Pérez-Sosa
Marcela Pérez-Sosa
AAAlejandro Agudelo
Alejandro Agudelo
DSDaniel Sánchez
Daniel Sánchez
AGAndres Gutierrez
Andres Gutierrez
Objective Hypospadias is a congenital disease of unknown etiology involving multiple epigenetic, genetic, and endocrinological factors. It is a highly incapacitating condition. Its surgical management is one of the most frequent surgical procedures done by pediatric urologists. Furthermore, the geographical distribution and healthcare access is limited in Colombia. The Colombian Ministry of Health has consolidated a nationwide registry called Integrated Social Protection Information System (SISPRO, in the Spanish acronym) to collect comprehensive information on the use and frequency of resources associated with health care in Colombia. The aim of the present study was to analyze the number of cases reported between 2014 and 2018 and the geographical distribution of access to healthcare of patients with hypospadias in Colombia. Methods An observational, retrospective study of hypospadias in Colombia, 2014–2018, was performed using data extracted from the Individual Health Records System (RIPS) in SISPRO. Satscan, version 9.6 was used to perform a distribution analysis of the georeferenced population using a Poisson model. To visualize the results, the software projected the result onto a Google Earth map. Results Between January 2014 and December 2018, a total of 8,990 cases of hypospadias were evaluated in Colombia. The geographical distribution in the national territory has areas with high evaluation rates. On average, the departments in which the majority of cases were evaluated during the study period were Bogotá, D.C., Antioquia, and Valle del Cauca (2,196, 1,818 and 1,151 cases, respectively). The statistical analysis of the space exploration (Fig. 1) identified the area with the highest concentration of cases (red) and the areas in which the lowest number of patients was evaluated (blue). The geographical distribution showed increasing trends in areas near the center of the country, especially in the cities of Bogotá, Cali, Ibagué, and Pereira. Conclusion There is a greater concentration of cases evaluated in the center of the country, where the cities with better access to subspecialized medical care are located. This highlights inequalities in health services and the opportunity for surgical care among regions of the country. If we consider that the prevalence rates of hypospadias remain stable, ∼ 87% of the patients with hypospadias will not be evaluated by a subspecialist.